JP6270477B2 - セグメント神経刺激リードのためのユーザインタフェース - Google Patents
セグメント神経刺激リードのためのユーザインタフェース Download PDFInfo
- Publication number
- JP6270477B2 JP6270477B2 JP2013524969A JP2013524969A JP6270477B2 JP 6270477 B2 JP6270477 B2 JP 6270477B2 JP 2013524969 A JP2013524969 A JP 2013524969A JP 2013524969 A JP2013524969 A JP 2013524969A JP 6270477 B2 JP6270477 B2 JP 6270477B2
- Authority
- JP
- Japan
- Prior art keywords
- electrodes
- stimulation
- electrode
- control element
- electrical stimulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000000638 stimulation Effects 0.000 claims description 384
- 230000007383 nerve stimulation Effects 0.000 claims description 46
- 230000004913 activation Effects 0.000 claims description 36
- 210000003484 anatomy Anatomy 0.000 claims description 25
- 230000001537 neural effect Effects 0.000 claims description 19
- 230000007423 decrease Effects 0.000 claims description 11
- 230000004044 response Effects 0.000 claims description 5
- 230000008859 change Effects 0.000 claims description 4
- 210000001519 tissue Anatomy 0.000 description 41
- 210000004556 brain Anatomy 0.000 description 33
- 238000006073 displacement reaction Methods 0.000 description 28
- 238000000034 method Methods 0.000 description 17
- 230000006870 function Effects 0.000 description 15
- 238000010586 diagram Methods 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 230000001965 increasing effect Effects 0.000 description 8
- 210000004281 subthalamic nucleus Anatomy 0.000 description 8
- 230000003247 decreasing effect Effects 0.000 description 6
- 230000004048 modification Effects 0.000 description 6
- 238000012986 modification Methods 0.000 description 6
- 239000003550 marker Substances 0.000 description 5
- 208000018737 Parkinson disease Diseases 0.000 description 4
- 238000004891 communication Methods 0.000 description 4
- 230000008901 benefit Effects 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 239000007943 implant Substances 0.000 description 3
- 238000002513 implantation Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 206010061818 Disease progression Diseases 0.000 description 2
- 206010021639 Incontinence Diseases 0.000 description 2
- 208000016285 Movement disease Diseases 0.000 description 2
- 208000012902 Nervous system disease Diseases 0.000 description 2
- 208000025966 Neurological disease Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000002146 bilateral effect Effects 0.000 description 2
- 208000022371 chronic pain syndrome Diseases 0.000 description 2
- 238000002591 computed tomography Methods 0.000 description 2
- 230000005750 disease progression Effects 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- 201000006517 essential tremor Diseases 0.000 description 2
- 210000000578 peripheral nerve Anatomy 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 208000014094 Dystonic disease Diseases 0.000 description 1
- 206010017577 Gait disturbance Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010023204 Joint dislocation Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 230000019771 cognition Effects 0.000 description 1
- 230000006999 cognitive decline Effects 0.000 description 1
- 208000010877 cognitive disease Diseases 0.000 description 1
- 230000003920 cognitive function Effects 0.000 description 1
- 238000005094 computer simulation Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000001054 cortical effect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000002059 diagnostic imaging Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037765 diseases and disorders Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 208000010118 dystonia Diseases 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000002594 fluoroscopy Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 229910052738 indium Inorganic materials 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000002595 magnetic resonance imaging Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000001009 nucleus accumben Anatomy 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 230000004043 responsiveness Effects 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 210000003625 skull Anatomy 0.000 description 1
- 201000002859 sleep apnea Diseases 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000003523 substantia nigra Anatomy 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 210000001103 thalamus Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 210000001030 ventral striatum Anatomy 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/372—Arrangements in connection with the implantation of stimulators
- A61N1/37211—Means for communicating with stimulators
- A61N1/37235—Aspects of the external programmer
- A61N1/37247—User interfaces, e.g. input or presentation means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0526—Head electrodes
- A61N1/0529—Electrodes for brain stimulation
- A61N1/0534—Electrodes for deep brain stimulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
- A61N1/36064—Epilepsy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
- A61N1/36067—Movement disorders, e.g. tremor or Parkinson disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
- A61N1/36071—Pain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
- A61N1/36082—Cognitive or psychiatric applications, e.g. dementia or Alzheimer's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36128—Control systems
- A61N1/36146—Control systems specified by the stimulation parameters
- A61N1/36182—Direction of the electrical field, e.g. with sleeve around stimulating electrode
- A61N1/36185—Selection of the electrode configuration
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36128—Control systems
- A61N1/36146—Control systems specified by the stimulation parameters
- A61N1/36182—Direction of the electrical field, e.g. with sleeve around stimulating electrode
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Radiology & Medical Imaging (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Developmental Disabilities (AREA)
- Psychiatry (AREA)
- Human Computer Interaction (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Business, Economics & Management (AREA)
- General Business, Economics & Management (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Primary Health Care (AREA)
- Electrotherapy Devices (AREA)
Description
本出願は、2010年8月18日に出願された米国仮特許出願第61/374,879号の35 U.S.C.§119に基づく優先権を主張する。上述した出願全体を、本明細書に援用する。
Claims (11)
- 神経刺激システム(10)と共に使用される外部制御装置(18)であって、
前記神経刺激システムは、神経刺激リード(12)と、前記神経刺激リード(12)の周りに周方向に配置された複数の電極(26)と、を有し、前記神経刺激リードは、前記電極(26)が埋込まれた組織の中に電気刺激フィールドを伝達することが可能であり、 前記外部制御装置は、ユーザインタフェースと、プロセッサ(80)と、出力回路(86)と、を有し、
前記ユーザインタフェースは、前記複数の電極(26)の3次元図形表現(26’)と、それと図形上で結合された複数のアイコン制御要素(130)と、電気刺激フィールド調整制御要素(116、118)とを表示するように構成された表示スクリーン(100)を含み、前記電気刺激フィールド調整制御要素(116、118)は、電気刺激フィールドの位置を変位させ且つ前記位置の周りの電気刺激フィールドの形状を変更させるように構成され、前記アイコン制御要素(130)の各々は、前記複数の電極(26)のうちの1つの電極の中を流れる電流を増減させるように構成され、且つ、インジケータ(134)を含み、前記インジケータ(134)は、前記電流の量を、前記複数の電極(26)の中を流れる全電流量のパーセントである分割電流値で示すように構成され、前記アイコン制御要素(130)及び前記電気刺激フィールド調整制御要素(116、118)のうちの一方を作動させたときに前記電極(26)の中を流れる電流の量を示すように構成され、
前記プロセッサは、前記アイコン制御要素(130)のうちの1つを作動させたときに前記電気刺激フィールドを調整するように設計された刺激パラメータを発生させるように構成され、
前記出力回路は、前記刺激パラメータを前記神経刺激システム(10)に送信するように構成される、外部制御装置(18)。 - 前記表示スクリーン(100)はタッチスクリーンである、請求項1に記載の外部制御装置(18)。
- 前記刺激パラメータは、作動させた前記アイコン制御要素(130)が図形上で結合している前記3次元図形表現の電極(26’)に対応する前記電極(26)を流れる電流の振幅を定める、請求項1に記載の外部制御装置(18)。
- 前記プロセッサ(80)は、前記発生させた刺激パラメータに基づいて、組織活性化容積(202)を推定するように構成され、
前記表示スクリーン(100)は、解剖学的構造(200)及び前記組織活性化容積(202)を、前記3次元図形表現の電極(26’)と別に表示するように構成され、
前記ユーザインタフェースは、作動されるように構成された制御要素(136、138)を含み、
前記プロセッサ(80)は、前記制御要素(136、138)の作動に応答して、前記3次元図形表現の電極(26’)と前記組織活性化容積(202)の両方を前記解剖学的構造(200)に対して同期して変位させるように構成される、請求項1に記載の外部制御装置(18)。 - 前記表示スクリーン(100)は、3次元図形表現の神経刺激リード(12’)を前記組織活性化容積(202)及び前記解剖学的構造(200)と一緒に表示するように構成され、
前記プロセッサ(80)は、前記制御要素(136、138)の作動に応答して、前記3次元図形表現の電極(26’)、前記組織活性化容積(202)、及び前記3次元図形表現の神経刺激リード(12’)を前記解剖学的構造(200)に対して同期して変位させるように構成される、請求項4に記載の外部制御装置(18)。 - 前記プロセッサ(80)は、前記制御要素(136、138)の作動に応答して、前記3次元図形表現の電極(26)及び前記組織活性化容積(202)を軸線方向に変位させるように構成される、請求項4に記載の外部制御装置(18)。
- 前記プロセッサ(80)は、前記制御要素(138)の作動に応答して、前記3次元図形表現の電極(26)及び前記組織活性化容積(202)を周方向に変位させるように構成される、請求項4に記載の外部制御装置(18)。
- 前記解剖学的構造(200)は、横断面図、冠状図、及び矢状図のうちの1つで表示される、請求項4に記載の外部制御装置(18)。
- 前記ユーザインタフェースは、作動されるように構成された別の制御要素(140)を含み、
前記プロセッサ(80)は、前記別の制御要素の作動に応答して、横断面図、冠状図、及び矢状図の1つを選択するように構成される、請求項4に記載の外部制御装置(18)。 - 前記出力回路(86)は遠隔測定回路を含む、請求項1に記載の外部制御装置(18)。
- 更に、ハウジングを有し、前記ハウジングは、前記ユーザインタフェース、前記プロセッサ(80)、及び前記出力回路(86)を収容する、請求項1に記載の外部制御装置(18)。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US37487910P | 2010-08-18 | 2010-08-18 | |
US61/374,879 | 2010-08-18 | ||
PCT/US2011/048144 WO2012024441A2 (en) | 2010-08-18 | 2011-08-17 | User interface for segmented neurostimulation leads |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016048881A Division JP6239663B2 (ja) | 2010-08-18 | 2016-03-11 | セグメント神経刺激リードのためのユーザインタフェース |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2013534175A JP2013534175A (ja) | 2013-09-02 |
JP2013534175A5 JP2013534175A5 (ja) | 2014-09-11 |
JP6270477B2 true JP6270477B2 (ja) | 2018-01-31 |
Family
ID=44534694
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2013524969A Active JP6270477B2 (ja) | 2010-08-18 | 2011-08-17 | セグメント神経刺激リードのためのユーザインタフェース |
JP2016048881A Expired - Fee Related JP6239663B2 (ja) | 2010-08-18 | 2016-03-11 | セグメント神経刺激リードのためのユーザインタフェース |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016048881A Expired - Fee Related JP6239663B2 (ja) | 2010-08-18 | 2016-03-11 | セグメント神経刺激リードのためのユーザインタフェース |
Country Status (7)
Country | Link |
---|---|
US (3) | US9411935B2 (ja) |
EP (3) | EP2605824B1 (ja) |
JP (2) | JP6270477B2 (ja) |
AU (2) | AU2011292025B2 (ja) |
CA (1) | CA2808641A1 (ja) |
ES (1) | ES2734359T3 (ja) |
WO (1) | WO2012024441A2 (ja) |
Families Citing this family (102)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7346382B2 (en) | 2004-07-07 | 2008-03-18 | The Cleveland Clinic Foundation | Brain stimulation models, systems, devices, and methods |
US8589316B2 (en) | 2009-08-27 | 2013-11-19 | The Cleveland Clinic Foundation | System and method to estimate region of tissue activation |
US9220889B2 (en) | 2008-02-11 | 2015-12-29 | Intelect Medical, Inc. | Directional electrode devices with locating features |
US8019440B2 (en) | 2008-02-12 | 2011-09-13 | Intelect Medical, Inc. | Directional lead assembly |
US9272153B2 (en) | 2008-05-15 | 2016-03-01 | Boston Scientific Neuromodulation Corporation | VOA generation system and method using a fiber specific analysis |
WO2011068997A1 (en) | 2009-12-02 | 2011-06-09 | The Cleveland Clinic Foundation | Reversing cognitive-motor impairments in patients having a neuro-degenerative disease using a computational modeling approach to deep brain stimulation programming |
JP5830090B2 (ja) | 2010-06-14 | 2015-12-09 | ボストン サイエンティフィック ニューロモデュレイション コーポレイション | 脊髄神経調節のためのプログラミングインターフェイス |
ES2734359T3 (es) | 2010-08-18 | 2019-12-05 | Boston Scient Neuromodulation Corp | Interfaz de usuario para cables de neuroestimulación segmentados |
US8706250B2 (en) | 2010-12-23 | 2014-04-22 | Boston Scientific Neuromodulation Corporation | Neurostimulation system for implementing model-based estimate of neurostimulation effects |
EP2654879B1 (en) | 2010-12-23 | 2018-06-27 | Boston Scientific Neuromodulation Corporation | Neurostimulation system for estimating desired stimulation amplitude for electrode configuration |
US8868196B2 (en) | 2011-03-15 | 2014-10-21 | Boston Scientific Neuromodulation Corporation | Neurostimulation system and method for rostro-caudally steering current using longitudinal ideal multipole configurations |
US8868197B2 (en) | 2011-03-15 | 2014-10-21 | Boston Scientific Neuromodulation Corporation | Neurostimulation system for defining ideal multipole configurations at lead boundary |
EP2522389A3 (en) * | 2011-05-13 | 2014-08-27 | Sergio Lara Pereira Monteiro | Animal and plant cell electric stimulator with randomized spatial distribution of electrodes for both current injection and for electric field shaping |
CA2828302A1 (en) | 2011-03-29 | 2012-10-04 | Boston Scientific Neuromodulation Corporation | Communication interface for therapeutic stimulation providing systems |
US9764140B2 (en) | 2011-05-17 | 2017-09-19 | Boston Scientific Neuromodulation Corporation | Display of region of activation in neurostimulation programming screen |
US9643015B2 (en) | 2011-05-27 | 2017-05-09 | Boston Scientific Neuromodilation Corporation | Collection of clinical data for graphical representation and analysis |
US9592389B2 (en) | 2011-05-27 | 2017-03-14 | Boston Scientific Neuromodulation Corporation | Visualization of relevant stimulation leadwire electrodes relative to selected stimulation information |
WO2013023085A2 (en) | 2011-08-09 | 2013-02-14 | Boston Scientific Neuromodulation Corporation | Systems and methods for stimulation-related volume analysis, creation, and sharing |
US9095712B2 (en) | 2012-05-29 | 2015-08-04 | Boston Scientific Neuromodulation Corporation | Electrical stimulation method for modulation on sensory information around dorsal root ganglia |
EP2879757B1 (en) | 2012-08-04 | 2019-06-26 | Boston Scientific Neuromodulation Corporation | Systems and methods for storing and transferring registration, atlas, and lead information between medical devices |
WO2014036081A1 (en) | 2012-08-28 | 2014-03-06 | Boston Scientific Neuromodulation Corporation | Capture and visualization of clinical effects data in relation to a lead and/or locus of stimulation |
US9615788B2 (en) | 2012-08-31 | 2017-04-11 | Nuvectra Corporation | Method and system of producing 2D representations of 3D pain and stimulation maps and implant models on a clinician programmer |
US8812125B2 (en) | 2012-08-31 | 2014-08-19 | Greatbatch Ltd. | Systems and methods for the identification and association of medical devices |
US9507912B2 (en) | 2012-08-31 | 2016-11-29 | Nuvectra Corporation | Method and system of simulating a pulse generator on a clinician programmer |
US9180302B2 (en) | 2012-08-31 | 2015-11-10 | Greatbatch Ltd. | Touch screen finger position indicator for a spinal cord stimulation programming device |
US8868199B2 (en) | 2012-08-31 | 2014-10-21 | Greatbatch Ltd. | System and method of compressing medical maps for pulse generator or database storage |
US8761897B2 (en) | 2012-08-31 | 2014-06-24 | Greatbatch Ltd. | Method and system of graphical representation of lead connector block and implantable pulse generators on a clinician programmer |
US8983616B2 (en) | 2012-09-05 | 2015-03-17 | Greatbatch Ltd. | Method and system for associating patient records with pulse generators |
US9375582B2 (en) | 2012-08-31 | 2016-06-28 | Nuvectra Corporation | Touch screen safety controls for clinician programmer |
US9594877B2 (en) | 2012-08-31 | 2017-03-14 | Nuvectra Corporation | Virtual reality representation of medical devices |
US10668276B2 (en) | 2012-08-31 | 2020-06-02 | Cirtec Medical Corp. | Method and system of bracketing stimulation parameters on clinician programmers |
US8903496B2 (en) | 2012-08-31 | 2014-12-02 | Greatbatch Ltd. | Clinician programming system and method |
US9471753B2 (en) | 2012-08-31 | 2016-10-18 | Nuvectra Corporation | Programming and virtual reality representation of stimulation parameter Groups |
US9259577B2 (en) | 2012-08-31 | 2016-02-16 | Greatbatch Ltd. | Method and system of quick neurostimulation electrode configuration and positioning |
US9767255B2 (en) | 2012-09-05 | 2017-09-19 | Nuvectra Corporation | Predefined input for clinician programmer data entry |
US8757485B2 (en) | 2012-09-05 | 2014-06-24 | Greatbatch Ltd. | System and method for using clinician programmer and clinician programming data for inventory and manufacturing prediction and control |
US20150223718A1 (en) | 2012-10-05 | 2015-08-13 | Inter-University Research Institute Corporation National Institutes Of Natural Sciences | Apparatus for acquiring electric activity in the brain and utilization of the same |
US9015087B2 (en) * | 2012-10-09 | 2015-04-21 | At&T Intellectual Property I, L.P. | Methods, systems, and products for interfacing with neurological and biological networks |
WO2014070290A2 (en) | 2012-11-01 | 2014-05-08 | Boston Scientific Neuromodulation Corporation | Systems and methods for voa model generation and use |
USD731550S1 (en) * | 2013-01-04 | 2015-06-09 | Samsung Electronics Co., Ltd. | Display screen or portion thereof with animated icon |
JP6198927B2 (ja) * | 2013-03-15 | 2017-09-20 | ボストン サイエンティフィック ニューロモデュレイション コーポレイション | 神経刺激システムにおける電流ステアリング方向プログラミングのための技術 |
US9993649B2 (en) * | 2013-04-05 | 2018-06-12 | Medtronic Bakken Research Center B.V. | System for planning and/or providing a therapy for neural applications |
EP3035884B1 (en) | 2013-08-13 | 2022-11-23 | Regents of the University of Minnesota | Computer visualization of anatomical items |
USD763269S1 (en) * | 2014-02-11 | 2016-08-09 | Samsung Electronics Co., Ltd. | Display screen or portion thereof with animated graphical user interface |
US9959388B2 (en) | 2014-07-24 | 2018-05-01 | Boston Scientific Neuromodulation Corporation | Systems, devices, and methods for providing electrical stimulation therapy feedback |
US10265528B2 (en) | 2014-07-30 | 2019-04-23 | Boston Scientific Neuromodulation Corporation | Systems and methods for electrical stimulation-related patient population volume analysis and use |
US10272247B2 (en) | 2014-07-30 | 2019-04-30 | Boston Scientific Neuromodulation Corporation | Systems and methods for stimulation-related volume analysis, creation, and sharing with integrated surgical planning and stimulation programming |
EP3185951A2 (en) * | 2014-08-26 | 2017-07-05 | Avent, Inc. | Selective nerve fiber block method and system |
EP3204112A1 (en) | 2014-10-07 | 2017-08-16 | Boston Scientific Neuromodulation Corporation | Systems, devices, and methods for electrical stimulation using feedback to adjust stimulation parameters |
US11051889B2 (en) | 2015-05-10 | 2021-07-06 | Alpha Omega Engineering Ltd. | Brain navigation methods and device |
JP6908328B2 (ja) | 2015-05-10 | 2021-07-21 | アルファ オメガ ニューロ テクノロジーズ リミテッド | 脳プローブ自動誘導システム |
US11234632B2 (en) | 2015-05-10 | 2022-02-01 | Alpha Omega Engineering Ltd. | Brain navigation lead |
US10814126B2 (en) * | 2015-05-22 | 2020-10-27 | Cochlear Limited | Dynamic current steering |
US10780283B2 (en) | 2015-05-26 | 2020-09-22 | Boston Scientific Neuromodulation Corporation | Systems and methods for analyzing electrical stimulation and selecting or manipulating volumes of activation |
AU2016268259B2 (en) | 2015-05-26 | 2019-01-31 | Boston Scientific Neuromodulation Corporation | Systems and methods for analyzing electrical stimulation and selecting or manipulating volumes of activation |
WO2017003946A1 (en) | 2015-06-29 | 2017-01-05 | Boston Scientific Neuromodulation Corporation | Systems and methods for selecting stimulation parameters based on stimulation target region, effects, or side effects |
WO2017003947A1 (en) | 2015-06-29 | 2017-01-05 | Boston Scientific Neuromodulation Corporation | Systems and methods for selecting stimulation parameters by targeting and steering |
WO2017035158A1 (en) | 2015-08-24 | 2017-03-02 | Boston Scientific Neuromodulation Corporation | Systems and methods for determining orientation of an electrical stimulation lead |
WO2017040573A1 (en) | 2015-09-01 | 2017-03-09 | Boston Scientific Neuromodulation Corporation | Detection of lead orientation |
US10456584B2 (en) | 2015-09-15 | 2019-10-29 | Boston Scientific Neuromodulation Corporation | User interface for neuromodulation lead |
EP3359252B1 (en) | 2015-10-09 | 2020-09-09 | Boston Scientific Neuromodulation Corporation | System and methods for clinical effects mapping for directional stimulations leads |
EP3411116B1 (en) | 2016-02-05 | 2020-01-22 | Boston Scientific Neuromodulation Corporation | Implantable optical stimulation lead |
US10716942B2 (en) | 2016-04-25 | 2020-07-21 | Boston Scientific Neuromodulation Corporation | System and methods for directional steering of electrical stimulation |
JP6905541B2 (ja) | 2016-06-24 | 2021-07-21 | ボストン サイエンティフィック ニューロモデュレイション コーポレイション | 臨床効果の視覚分析のためのシステム及び方法 |
WO2018031558A1 (en) | 2016-08-12 | 2018-02-15 | Boston Scientific Scimed, Inc. | Distributed interactive medical visualization system with primary/secondary interaction features |
CN109564785A (zh) | 2016-08-12 | 2019-04-02 | 波士顿科学国际有限公司 | 具有用户界面特征的分布式交互医学可视化系统 |
WO2018044881A1 (en) | 2016-09-02 | 2018-03-08 | Boston Scientific Neuromodulation Corporation | Systems and methods for visualizing and directing stimulation of neural elements |
US10780282B2 (en) | 2016-09-20 | 2020-09-22 | Boston Scientific Neuromodulation Corporation | Systems and methods for steering electrical stimulation of patient tissue and determining stimulation parameters |
WO2018063912A1 (en) | 2016-09-27 | 2018-04-05 | Boston Scientific Neuromodulation Corporation | Systems and methods for closed-loop pain management |
WO2018063637A1 (en) | 2016-09-27 | 2018-04-05 | Boston Scientific Neuromodulation Corporation | System for pain management using objective pain measure |
WO2018071420A1 (en) | 2016-10-14 | 2018-04-19 | Boston Scientific Neuromodulation Corporation | Orientation marker for implantable leads, and leads and systems utilizing the orientation marker |
ES2869184T3 (es) | 2016-10-14 | 2021-10-25 | Boston Scient Neuromodulation Corp | Sistemas para determinar en lazo cerrado la configuración de los parámetros de estimulación de un sistema de estimulación eléctrica |
US10625072B2 (en) | 2016-10-21 | 2020-04-21 | Boston Scientific Neuromodulation Corporation | Electrical stimulation methods with optical observation and devices therefor |
WO2018128949A1 (en) | 2017-01-03 | 2018-07-12 | Boston Scientific Neuromodulation Corporation | Systems and methods for selecting mri-compatible stimulation parameters |
US10589104B2 (en) | 2017-01-10 | 2020-03-17 | Boston Scientific Neuromodulation Corporation | Systems and methods for creating stimulation programs based on user-defined areas or volumes |
US10675469B2 (en) * | 2017-01-11 | 2020-06-09 | Boston Scientific Neuromodulation Corporation | Pain management based on brain activity monitoring |
WO2018132535A1 (en) | 2017-01-11 | 2018-07-19 | Boston Scientific Neuromodulation Corporation | Pain management based on emotional expression measurements |
US10960210B2 (en) | 2017-02-10 | 2021-03-30 | Boston Scientific Neuromodulation Corporation | Method and apparatus for pain management with sleep detection |
US10625082B2 (en) | 2017-03-15 | 2020-04-21 | Boston Scientific Neuromodulation Corporation | Visualization of deep brain stimulation efficacy |
WO2018187090A1 (en) | 2017-04-03 | 2018-10-11 | Boston Scientific Neuromodulation Corporation | Systems and methods for estimating a volume of activation using a compressed database of threshold values |
US10631937B2 (en) | 2017-04-14 | 2020-04-28 | Boston Scientific Neuromodulation Corporation | Systems and methods for determining orientation of an implanted electrical stimulation lead |
WO2019005689A1 (en) | 2017-06-26 | 2019-01-03 | Boston Scientific Neuromodulation Corporation | SYSTEMS AND METHODS FOR VISUALIZING AND CONTROLLING OPTOGENETIC STIMULATION USING OPTICAL STIMULATION SYSTEMS |
AU2018301355B2 (en) | 2017-07-14 | 2020-10-01 | Boston Scientific Neuromodulation Corporation | Systems and methods for estimating clinical effects of electrical stimulation |
US10898718B2 (en) | 2017-07-18 | 2021-01-26 | Boston Scientific Neuromoduiation Corporation | Sensor-based pain management systems and methods |
EP3634569A1 (en) | 2017-08-15 | 2020-04-15 | Boston Scientific Neuromodulation Corporation | Systems and methods for controlling electrical stimulation using multiple stimulation fields |
EP3684463A4 (en) | 2017-09-19 | 2021-06-23 | Neuroenhancement Lab, LLC | NEURO-ACTIVATION PROCESS AND APPARATUS |
US11717686B2 (en) | 2017-12-04 | 2023-08-08 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement to facilitate learning and performance |
US11318277B2 (en) | 2017-12-31 | 2022-05-03 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement to enhance emotional response |
EP3737464A1 (en) | 2018-01-11 | 2020-11-18 | Boston Scientific Neuromodulation Corporation | Methods and systems for stimulation for glial modulation |
US20190282799A1 (en) | 2018-03-15 | 2019-09-19 | Avent, Inc. | Percutaneous lead |
WO2019183054A1 (en) | 2018-03-23 | 2019-09-26 | Boston Scientific Neuromodulation Corporation | Optical stimulation systems with calibration and methods of making and using |
WO2019183068A1 (en) | 2018-03-23 | 2019-09-26 | Boston Scientific Neuromodulation Corporation | An optical stimulation system with on-demand monitoring and methods of making and using |
US11364361B2 (en) | 2018-04-20 | 2022-06-21 | Neuroenhancement Lab, LLC | System and method for inducing sleep by transplanting mental states |
US11285329B2 (en) | 2018-04-27 | 2022-03-29 | Boston Scientific Neuromodulation Corporation | Systems and methods for visualizing and programming electrical stimulation |
AU2019260740B2 (en) | 2018-04-27 | 2022-05-19 | Boston Scientific Neuromodulation Corporation | Multi-mode electrical stimulation systems and methods of making and using |
EP3849410A4 (en) | 2018-09-14 | 2022-11-02 | Neuroenhancement Lab, LLC | SLEEP ENHANCEMENT SYSTEM AND METHOD |
US11224743B2 (en) | 2018-09-21 | 2022-01-18 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using modular leads for electrical stimulation systems |
WO2020102039A1 (en) | 2018-11-16 | 2020-05-22 | Boston Scientific Neuromodulation Corporation | An optical stimulation system with on-demand monitoring and methods of making |
US11341717B2 (en) * | 2020-01-03 | 2022-05-24 | Medtronic, Inc. | Graphical display of volume of activation |
WO2022051295A1 (en) | 2020-09-04 | 2022-03-10 | Boston Scientific Neuromodulation Corporation | Stimulation systems with a lens arrangement for light coupling and methods of making and using |
WO2022103590A1 (en) | 2020-11-11 | 2022-05-19 | Boston Scientific Neuromodulation Corporation | Voice command handler for programming stimulation systems and methods of using |
US20240136047A1 (en) | 2022-10-19 | 2024-04-25 | Boston Scientific Neuromodulation Corporation | Neuroanatomy-based Search to Optimize Trajectory Selection during DBS Targeting |
Family Cites Families (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6393325B1 (en) | 1999-01-07 | 2002-05-21 | Advanced Bionics Corporation | Directional programming for implantable electrode arrays |
US6516227B1 (en) | 1999-07-27 | 2003-02-04 | Advanced Bionics Corporation | Rechargeable spinal cord stimulator system |
US7050857B2 (en) * | 1999-12-16 | 2006-05-23 | St. Jude Medical Ab | Programming system for medical devices |
US6845267B2 (en) | 2000-09-28 | 2005-01-18 | Advanced Bionics Corporation | Systems and methods for modulation of circulatory perfusion by electrical and/or drug stimulation |
US6950707B2 (en) | 2000-11-21 | 2005-09-27 | Advanced Bionics Corporation | Systems and methods for treatment of obesity and eating disorders by electrical brain stimulation and/or drug infusion |
US6993384B2 (en) | 2001-12-04 | 2006-01-31 | Advanced Bionics Corporation | Apparatus and method for determining the relative position and orientation of neurostimulation leads |
AUPS318202A0 (en) * | 2002-06-26 | 2002-07-18 | Cochlear Limited | Parametric fitting of a cochlear implant |
US7641686B2 (en) | 2004-04-23 | 2010-01-05 | Direct Flow Medical, Inc. | Percutaneous heart valve with stentless support |
US7346382B2 (en) | 2004-07-07 | 2008-03-18 | The Cleveland Clinic Foundation | Brain stimulation models, systems, devices, and methods |
US8019439B2 (en) | 2005-01-11 | 2011-09-13 | Boston Scientific Neuromodulation Corporation | Lead assembly and method of making same |
US7640059B2 (en) | 2005-09-08 | 2009-12-29 | Medtronic, Inc. | External presentation of electrical stimulation parameters |
US7650184B2 (en) | 2005-12-01 | 2010-01-19 | Boston Scientific Neuromodulation Corporation | Cylindrical multi-contact electrode lead for neural stimulation and method of making same |
US7657319B2 (en) | 2006-02-24 | 2010-02-02 | Medtronic, Inc. | Programming interface with an unwrapped 2D view of a stimulation lead with complex electrode array geometry |
US7826902B2 (en) * | 2006-02-24 | 2010-11-02 | Medtronic, Inc. | User interface with 2D views for configuring stimulation therapy |
US7676273B2 (en) * | 2006-02-24 | 2010-03-09 | Medtronic, Inc. | Stimulation templates for programming a stimulation lead with complex electrode array geometry |
US20070203538A1 (en) * | 2006-02-24 | 2007-08-30 | Medtronic, Inc. | User interface with an atlas for configuring stimulation therapy |
US7822483B2 (en) * | 2006-02-24 | 2010-10-26 | Medtronic, Inc. | Electrical and activation field models for configuring stimulation therapy |
US8612024B2 (en) * | 2006-02-24 | 2013-12-17 | Medtronic, Inc. | User interface with 3D environment for configuring stimulation therapy |
EP2059294B1 (en) * | 2006-08-07 | 2018-10-10 | Alpha Omega Neuro Technologies Ltd. | Cerebral electrodes |
US7742819B2 (en) | 2006-11-07 | 2010-06-22 | Boston Scientific Neuromodulation Corporation | System and method for uniformly displacing a region of neural stimulation |
WO2008070140A2 (en) * | 2006-12-06 | 2008-06-12 | Medtronic, Inc. | User interface with toolbar for programming electrical stimulation therapy |
US20090018617A1 (en) * | 2007-04-30 | 2009-01-15 | Medtronic, Inc. | Parameter-directed shifting of electrical stimulation electrode combinations |
US9248280B2 (en) * | 2007-11-02 | 2016-02-02 | Boston Scientific Neuromodulation Corporation | Closed-loop feedback for steering stimulation energy within tissue |
US20100001566A1 (en) | 2008-02-13 | 2010-01-07 | Aviezer Yehuda | Rocker device for infant seat |
WO2009134475A1 (en) * | 2008-04-29 | 2009-11-05 | Medtronic, Inc. | Therapy program modification based on a therapy field model |
WO2009139917A2 (en) | 2008-05-15 | 2009-11-19 | Intelect Medical, Inc. | Clinician programmer clinician programmer system and method for generating interface models and displays of volumes of activation |
US20090326608A1 (en) * | 2008-06-25 | 2009-12-31 | Huynh Jeffrey C | Method of electrically stimulating tissue of a patient by shifting a locus of stimulation and system employing the same |
US9278222B2 (en) * | 2008-07-11 | 2016-03-08 | Boston Scientific Neuromodulation Corporation | System and method for converting tissue stimulation programs in a format usable by an electrical current steering navigator |
WO2010011969A1 (en) | 2008-07-24 | 2010-01-28 | Boston Scientific Neuromodulation Corporation | System and method for avoiding, reversing, and managing neurological accomodation to electrical stimulation |
US9987493B2 (en) * | 2008-10-28 | 2018-06-05 | Medtronic, Inc. | Medical devices and methods for delivery of current-based electrical stimulation therapy |
US20100121409A1 (en) * | 2008-11-12 | 2010-05-13 | Sridhar Kothandaraman | System and method for determining appropriate steering tables for distributing stimulation energy among multiple neurostimulation electrodes |
CA2745435C (en) * | 2008-12-04 | 2020-04-14 | The Cleveland Clinic Foundation | System and method to define target volume for stimulation in brain |
US9320901B2 (en) * | 2010-04-28 | 2016-04-26 | Medtronic, Inc. | Stimulation with utilization of non-selected electrode |
ES2734359T3 (es) | 2010-08-18 | 2019-12-05 | Boston Scient Neuromodulation Corp | Interfaz de usuario para cables de neuroestimulación segmentados |
-
2011
- 2011-08-17 ES ES13156700T patent/ES2734359T3/es active Active
- 2011-08-17 AU AU2011292025A patent/AU2011292025B2/en active Active
- 2011-08-17 WO PCT/US2011/048144 patent/WO2012024441A2/en active Application Filing
- 2011-08-17 EP EP11750031.4A patent/EP2605824B1/en active Active
- 2011-08-17 EP EP13156700.0A patent/EP2630987B1/en active Active
- 2011-08-17 JP JP2013524969A patent/JP6270477B2/ja active Active
- 2011-08-17 EP EP19179117.7A patent/EP3574953B1/en active Active
- 2011-08-17 CA CA2808641A patent/CA2808641A1/en not_active Abandoned
- 2011-08-17 US US13/212,063 patent/US9411935B2/en active Active
-
2016
- 2016-03-11 JP JP2016048881A patent/JP6239663B2/ja not_active Expired - Fee Related
- 2016-07-12 US US15/208,413 patent/US9931512B2/en active Active
- 2016-12-01 AU AU2016266054A patent/AU2016266054B2/en active Active
-
2018
- 2018-02-20 US US15/900,644 patent/US10744330B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2016105862A (ja) | 2016-06-16 |
EP2605824A2 (en) | 2013-06-26 |
EP3574953B1 (en) | 2023-09-27 |
CA2808641A1 (en) | 2012-02-23 |
US9931512B2 (en) | 2018-04-03 |
AU2016266054B2 (en) | 2017-11-30 |
JP2013534175A (ja) | 2013-09-02 |
AU2011292025B2 (en) | 2016-09-01 |
US10744330B2 (en) | 2020-08-18 |
US9411935B2 (en) | 2016-08-09 |
EP2605824B1 (en) | 2019-07-24 |
AU2011292025A1 (en) | 2013-02-28 |
ES2734359T3 (es) | 2019-12-05 |
AU2016266054A1 (en) | 2016-12-22 |
US20160317824A1 (en) | 2016-11-03 |
JP6239663B2 (ja) | 2017-11-29 |
WO2012024441A2 (en) | 2012-02-23 |
EP3574953A1 (en) | 2019-12-04 |
US20180178021A1 (en) | 2018-06-28 |
EP2630987A1 (en) | 2013-08-28 |
US20120046715A1 (en) | 2012-02-23 |
WO2012024441A3 (en) | 2012-05-03 |
EP2630987B1 (en) | 2019-05-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6239663B2 (ja) | セグメント神経刺激リードのためのユーザインタフェース | |
US11957915B2 (en) | Collection of clinical data for graphical representation and analysis | |
JP5974019B2 (ja) | 活性化容積を選択的に見積って治療を行う神経刺激システム | |
JP6341855B2 (ja) | 刺激器プログラムのための視覚化支援として使用するユーザ定義のグラフィック形状 | |
JP6073866B2 (ja) | 神経刺激プログラム画面における活性化領域の表示 | |
US10709893B2 (en) | System and method for providing fluid real-time visualization of region of tissue activation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130422 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130925 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140725 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20140725 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20150313 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20150413 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150713 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20151111 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160311 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20160323 |
|
A912 | Re-examination (zenchi) completed and case transferred to appeal board |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20160527 |
|
RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20170412 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20170627 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170825 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20171226 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6270477 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |